UPDATE 1-Sanofi to name new CEO in coming weeks as euro lifts results
* 2014 business EPS growth beats analysts' average estimate
* Chairman Weinberg says will announce new CEO by end-Q1
* Weinberg says has stabilised Lantus market share in United States (Adds details)
By Andrew Callus and Gilles Guillaume
PARIS, Feb 5 (Reuters) - French drugs firm Sanofi said on Thursday it would be in a position to name a new chief executive in the coming weeks as it delivered 1.5 percent quarterly earnings per share growth thanks to the weak euro.
"The announcement will be before the end of the first quarter," said Chairman Serge Weinberg, who has been acting CEO since Chris Viehbacher was fired at the end of October for poor execution of strategy and lack of communication with the board.
Analysts have said the company's apparent difficulty finding a new CEO after some potential candidates appeared to reject approaches has been weighing on investor sentiment.
A poor sales performance by its key Lantus diabetes drug in the United States was one of the reasons cited for the sacking.
Weinberg said on a quarterly results conference call on Thursday that he had stabilised Lantus' U.S. market share after replacing more than a third of the people running the business. Continuación...